Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed Sells 34,288 Shares

Outset Medical, Inc. (NASDAQ:OMGet Free Report) CFO Nabeel Ahmed sold 34,288 shares of Outset Medical stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $0.80, for a total value of $27,430.40. Following the completion of the transaction, the chief financial officer now owns 258,869 shares in the company, valued at approximately $207,095.20. This represents a 11.70 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Nabeel Ahmed also recently made the following trade(s):

  • On Monday, January 13th, Nabeel Ahmed sold 29,031 shares of Outset Medical stock. The shares were sold at an average price of $0.81, for a total transaction of $23,515.11.
  • On Tuesday, January 7th, Nabeel Ahmed sold 1,835 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $2,367.15.
  • On Friday, November 15th, Nabeel Ahmed sold 4,221 shares of Outset Medical stock. The shares were sold at an average price of $0.80, for a total transaction of $3,376.80.

Outset Medical Trading Down 3.3 %

Outset Medical stock opened at $0.78 on Thursday. The business has a 50 day moving average of $1.01 and a 200-day moving average of $1.28. Outset Medical, Inc. has a 1 year low of $0.44 and a 1 year high of $5.22. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12.

Hedge Funds Weigh In On Outset Medical

Several institutional investors and hedge funds have recently added to or reduced their stakes in the business. National Bank of Canada FI lifted its stake in shares of Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock worth $35,000 after acquiring an additional 23,164 shares during the period. Huntington National Bank increased its position in Outset Medical by 46.2% during the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock valued at $43,000 after purchasing an additional 20,000 shares during the period. Vanguard Personalized Indexing Management LLC bought a new position in Outset Medical during the 2nd quarter worth approximately $49,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of Outset Medical in the 2nd quarter worth approximately $259,000. Finally, Squarepoint Ops LLC boosted its stake in shares of Outset Medical by 74.1% in the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock valued at $309,000 after purchasing an additional 34,187 shares during the last quarter.

Analysts Set New Price Targets

Separately, Royal Bank of Canada reiterated a “sector perform” rating and set a $3.00 price target on shares of Outset Medical in a report on Tuesday, January 7th.

Get Our Latest Report on OM

About Outset Medical

(Get Free Report)

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.

Featured Stories

Insider Buying and Selling by Quarter for Outset Medical (NASDAQ:OM)

Receive News & Ratings for Outset Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Outset Medical and related companies with MarketBeat.com's FREE daily email newsletter.